Jul 062017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, announced today that it has completed a $20.5 million second closing of its Series C financing, bringing the total amount of capital raised for its Series C to $35 million.… => Read more

Axonics Modulation Technologies adds Geoff Pardo to its Board along with raising $20.5m in Series C financing

From:: Axonics Modulation Technologies adds Geoff Pardo to its Board along with raising $20.5m in Series C financing

Sorry, the comment form is closed at this time.

%d bloggers like this: